Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway.

Transl Lung Cancer Res · 2022 · PMC9271429 · PMID 35832442

Europe PMC DOI

hedged sentence

0.0893

closest p · 1.8× alpha

0.0893

boldest claim

The sentences

marginally significantP=0.0893so close (0.05 < p ≤ 0.1)

The correlation analysis between different IHC staining intensity of STT3A and clinicopathological factors showed that only the lymph node status and metastasis were marginally significant (chi-square test, P=0.0893, P=0.0791; see Table S1 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.